AR038552A2 - Analogos proteicos relacionados con la hormona paratiroides - Google Patents

Analogos proteicos relacionados con la hormona paratiroides

Info

Publication number
AR038552A2
AR038552A2 ARP030100515A ARP030100515A AR038552A2 AR 038552 A2 AR038552 A2 AR 038552A2 AR P030100515 A ARP030100515 A AR P030100515A AR P030100515 A ARP030100515 A AR P030100515A AR 038552 A2 AR038552 A2 AR 038552A2
Authority
AR
Argentina
Prior art keywords
acc
cha
aib
leu
lys
Prior art date
Application number
ARP030100515A
Other languages
English (en)
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Publication of AR038552A2 publication Critical patent/AR038552A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Análogos proteicos relacionados con la hormona paratiroides, que comprende la fórmula (R1R2)A1-Val-A3-Glu-A5-Gln-A7-A8-His-A10-A11-A12-Lys-A14-A15-A16-A17-A18-A19-Arg-Arg-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-R3 donde: A1 es Ala, Ser o Dap; A3 es Ser, o Aib; A5 es His, Ile, Acc, o Cha; A7 es Leu, Cha, Nle, b-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halógeno o CH3; A8 es Leu, Met, Acc, o Cha; A10 es Asp o Asn; A11 es Lys, Leu, Cha, Acc, Phe, o b-Nal; A12 es Gly, Acc, o Aib; A14 Ser o His; A15 es Ile, Acc, o Cha; A16 es Gln o Aib; A17 es Asp o Aib; A18 es Leu, Aib, Acc, o Cha; A19 es Arg o Aib; A22 es Phe, Glu, Aib, Acc o Cha; A23 es Phe, Leu, Lys, Acc o Cha; A24 es Leu, Lys, Acc o Cha; A25 es His, Lys, Aib, Acc o Glu; A26 es His, Aib, Acc o Lys; A27 es Leu, Lys, Acc o Cha; A28 es Ile, Leu, Lys, Acc o Cha; A29 es Ala, Glu, Acc o Aib; A30 es Glu, Leu, Nle, Cha, Aib, Acc, o Lys; A31 es Ile, Leu, Cha, Lys, Acc o está suprimido; A32 es His o está suprimido; A33 es Thr o está suprimido; A34 es Ala o está suprimido; cada uno de R1 o R2, es, en forma independiente, H, alcanilo C1-12, fenilalquilo C7-20, naftilalquilo C11-20, hidroxialquilo C1-12; hidroxialquenilo C2-12; hidrofenilalquilo C7-20; hidroxinaftilalquilo C11-20; o uno y solamente uno de R1 y R2 es COE1, donde E1 es alquilo C1-12; alquilo C2-12; alquenilo C2-12; fenilalquilo C7-20; naftilalquilo C11-20, hidroxialquilo C1-12; hidroxialquenilo C2-12; hidroxifenilalquilo C7-20; o hidroxinaftilalquilo C11-20; y R3 es OH, NH2, alcoxi C1-12; o NH-Y-CH2-Z, donde Y, es una porción de hidrocarburo C1-12; y Z es H, OH, CO2H, o CONH2; siempre que la menos uno de A5, A7, A8, A11, A12, A15, A18, A22, A23, A24, A25, A26, A27, A28, A29, A30, o A31, sea Acc; o una sal farmacéuticamente aceptable de los mismos.
ARP030100515A 1997-01-07 2003-02-17 Analogos proteicos relacionados con la hormona paratiroides AR038552A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone

Publications (1)

Publication Number Publication Date
AR038552A2 true AR038552A2 (es) 2005-01-19

Family

ID=27119618

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980100058A AR011517A1 (es) 1997-01-07 1998-01-06 Analogos proteicos relacionados con la hormona paratiroides
ARP030100515A AR038552A2 (es) 1997-01-07 2003-02-17 Analogos proteicos relacionados con la hormona paratiroides
ARP060100191A AR051906A2 (es) 1997-01-07 2006-01-18 Analogos proteicos relacionados con la hormona paratiroides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980100058A AR011517A1 (es) 1997-01-07 1998-01-06 Analogos proteicos relacionados con la hormona paratiroides

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP060100191A AR051906A2 (es) 1997-01-07 2006-01-18 Analogos proteicos relacionados con la hormona paratiroides

Country Status (24)

Country Link
US (1) US5955574A (es)
EP (3) EP1645566B1 (es)
JP (1) JP3963482B2 (es)
KR (2) KR100497709B1 (es)
CN (1) CN1137898C (es)
AR (3) AR011517A1 (es)
AT (2) ATE471342T1 (es)
AU (1) AU741584B2 (es)
BR (1) BR9714200A (es)
CA (1) CA2276614C (es)
CZ (2) CZ298937B6 (es)
DE (2) DE69739912D1 (es)
DK (2) DK0948541T3 (es)
ES (2) ES2258286T3 (es)
HK (1) HK1026215A1 (es)
HU (1) HUP9904596A3 (es)
IL (1) IL130794A0 (es)
NO (1) NO993341L (es)
NZ (1) NZ336610A (es)
PL (1) PL191898B1 (es)
PT (2) PT1645566E (es)
RU (1) RU2198182C2 (es)
SI (2) SI0948541T1 (es)
WO (1) WO1998030590A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US6544949B1 (en) 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
HU226866B1 (en) * 1997-09-09 2009-12-28 Hoffmann La Roche Fracture healing using pthrp analogs
WO1999057139A2 (en) * 1998-05-05 1999-11-11 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Pth2 receptor selective compounds
CZ2001253A3 (cs) * 1998-07-20 2001-11-14 Societe De Conseils De Recherches Et D'application Peptidové analogy PACAP
US6660843B1 (en) † 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6489297B1 (en) 2000-02-18 2002-12-03 Dabur Research Foundation Vasoactive intestinal peptide analogs
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
KR101320817B1 (ko) 2001-06-01 2013-10-21 노파르티스 아게 부갑상선 호르몬 및 칼시토닌의 경구 투여
WO2003009804A2 (en) 2001-07-23 2003-02-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
WO2005016265A2 (en) * 2003-08-06 2005-02-24 Rhodia Inc. Method for promoting bone growth
CA2628945A1 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
CN102274492B (zh) * 2006-10-03 2014-11-26 半径健康公司 骨合成代谢蛋白质的药物递送方法
PL2084183T3 (pl) * 2006-10-13 2010-10-29 Lilly Co Eli Pegylowane pth jako modulatory receptora pth i ich zastosowania
US8568737B2 (en) 2007-08-01 2013-10-29 The General Hospital Corporation Screening methods using G-protein coupled receptors and related compositions
EP2411038B1 (en) 2009-03-27 2016-12-28 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20130053448A1 (en) 2010-05-12 2013-02-28 Louis O'Dea Therapeutic Regimens
US9492508B2 (en) 2010-05-13 2016-11-15 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
EP4039253A1 (en) 2015-04-29 2022-08-10 Radius Pharmaceuticals, Inc. Methods of treating cancer
WO2017007777A2 (en) * 2015-07-06 2017-01-12 Zhengxin Dong NOVEL FORMULATIONS OF PTHrP ANALOGUE
WO2017223115A1 (en) 2016-06-22 2017-12-28 Radius Health, Inc. Ar+ breast cancer treatment methods
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (en) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
WO1990010067A1 (de) * 1989-02-23 1990-09-07 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
PL174772B1 (pl) 1993-01-06 1998-09-30 Kinerton Ltd Kompozycja farmaceutyczna zawierająca jonowy konjugat cząsteczkowy
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
WO1996019246A1 (en) * 1994-12-19 1996-06-27 Beth Israel Hospital Association Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
CN1137898C (zh) 2004-02-11
AR051906A2 (es) 2007-02-14
ES2258286T3 (es) 2006-08-16
DK1645566T3 (da) 2010-09-27
CZ301497B6 (cs) 2010-03-24
ES2347154T3 (es) 2010-10-26
DE69735603D1 (de) 2006-05-18
DK0948541T3 (da) 2006-07-17
CZ239899A3 (cs) 2000-01-12
EP1645566A2 (en) 2006-04-12
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
NZ336610A (en) 2001-07-27
JP2001508439A (ja) 2001-06-26
NO993341L (no) 1999-09-06
CZ298937B6 (cs) 2008-03-19
EP2206725A1 (en) 2010-07-14
IL130794A0 (en) 2001-01-28
PT948541E (pt) 2006-07-31
KR20060030006A (ko) 2006-04-07
ATE321784T1 (de) 2006-04-15
EP1645566B1 (en) 2010-06-16
RU2198182C2 (ru) 2003-02-10
CA2276614A1 (en) 1998-07-16
DE69735603T2 (de) 2006-11-30
SI1645566T1 (sl) 2010-11-30
HK1026215A1 (en) 2000-12-08
ATE471342T1 (de) 2010-07-15
SI0948541T1 (sl) 2006-06-30
EP0948541A2 (en) 1999-10-13
CA2276614C (en) 2002-06-11
AU5519998A (en) 1998-08-03
KR100699422B1 (ko) 2007-03-28
BR9714200A (pt) 2000-03-28
PT1645566E (pt) 2010-08-31
WO1998030590A2 (en) 1998-07-16
AU741584B2 (en) 2001-12-06
AR011517A1 (es) 2000-08-30
EP0948541B1 (en) 2006-03-29
KR100497709B1 (ko) 2005-06-23
US5955574A (en) 1999-09-21
HUP9904596A1 (hu) 2000-06-28
DE69739912D1 (de) 2010-07-29
EP1645566A3 (en) 2006-10-11
KR20000069952A (ko) 2000-11-25
PL334438A1 (en) 2000-02-28
CN1254347A (zh) 2000-05-24
HUP9904596A3 (en) 2000-07-28
WO1998030590A9 (en) 1999-08-19
JP3963482B2 (ja) 2007-08-22
WO1998030590A3 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
AR038552A2 (es) Analogos proteicos relacionados con la hormona paratiroides
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
HUP0104579A2 (hu) GLP-1 analógok, ezeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása
BR0316670A (pt) Anticorpos quiméricos e humanizados para integrina (alfa)5ß1 que modulam a angiogênese
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
HUP9901209A2 (hu) Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
TR200003721T2 (tr) Spreyler için farmasötik formülasyonlar
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DE69803750T2 (de) Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften
FI962584A (fi) Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä
BR9913457A (pt) Neuroproteção
ATE228360T1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
BR9707064A (pt) Novos derivados 19-nor-pregneno
DE69938064D1 (de) Aminoterminal modifizierte parathyroidhormon (pth) analoge
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
KR920014777A (ko) 치환된1,2,3,4-테트라하이드로사이클로펜트[b]인돌 1,2,3,3a,4,8a-헥사하이드로사이클로펜트[b]인돌 및 관련 화합물, 이의 중간체 및 제조방법 및 약제로서의 이의용도
HUP0105308A2 (hu) Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények
HUP9901212A2 (hu) N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk
DE69333660D1 (de) Pct-65 serotonin rezeptor
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ATE282608T1 (de) Chinoxalindionen
CA2307068A1 (en) Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
KR880006223A (ko) 12- 할로겐화 포스콜린 유도체, 중간체 및 이의 제조방법, 및 약제로서의 이의 용도
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.

Legal Events

Date Code Title Description
FG Grant, registration